Charles River Laboratories International (CRL) EPS (Basic) (2009 - 2026)

Charles River Laboratories International has reported EPS (Basic) for 18 years, with the latest figure at -$0.02 in Q2 2026.

• On a quarterly basis, EPS (Basic) fell 101.49% year-over-year to -$0.02 in Q2 2026; TTM through Jun 2026 was -$4.95, a 251.43% decrease from a year earlier, with the FY2025 full-year figure at -$2.91, down 1553.11% from the prior year.
• EPS (Basic) was -$0.02 for Q2 2026 at Charles River Laboratories International, up from -$0.3 in the prior quarter.
• The five-year high for EPS (Basic) was $3.72 in Q4 2022, with the low at -$5.58 in Q4 2025.
• Average EPS (Basic) over 5 years is $0.89, with a median of $1.52 recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: EPS (Basic) soared 47.0% in 2022, then slumped 214.95% in 2024.
• Over 5 years, EPS (Basic) stood at $3.72 in 2022, then declined by 1.87% to $3.65 in 2023, then plunged by 214.95% to -$4.2 in 2024, then tumbled by 32.91% to -$5.58 in 2025, then soared by 99.72% to -$0.02 in 2026.
• The last three EPS (Basic) figures came in at -$0.02 (Q2 2026), -$0.3 (Q1 2026), and -$5.58 (Q4 2025), per Business Quant data.